Objective: In this study, we aimed to investigate the association of epicardial fat thickness (EFT) and coronary artery lesion complexity with patients having acute non-ST elevation myocardial infarction (NSTEMI).
INTRODUCTION
Obesity has been accepted as an important risk factor in the development of atherosclerotic cardiovascular disease (1) . A marked increase in local body adipose tissue has been shown to play a significant role in atherosclerotic cardiovascular heart disease (2).
The epicardial fat tissue is a regional visceral deposit of adipose tissue located between the myocardium and visceral pericardium, particularly around subepicardial coronary vessels (3) . It acts as an endocrine and paracrine organ, secreting many proinflammatory and proatherogenic cytokines that are involved in plaque formation, plaque instability, accelerated atherosclerosis, and arterial thrombosis (4) (5) (6) (7) (8) (9) (10) (11) (12) .
Several studies have shown the association between epicardial fat thickness (EFT) and atherosclerotic coronary disease by means of transthoracic echocardiography (TTE), magnetic resonance imaging (MRI), and computerized tomography (CT) (13, 14) . EFT is associated with the severity and burden of coronary artery disease (CAD) (6, 7, 12) . In this study, we investigated the association between EFT and the severity of CAD in patients with non-ST elevation myocardial infarction (NSTEMI) using TTE.
MATERIALS and METHODS

Study design
We included 328 consecutive patients (n=328) with NSTEMI who underwent coronary angiography (CAG). Diagnoses for NSTEMI were defined according to the American College of Cardiology guidelines (15). The patients were divided into three groups based on the syntax score (SS). The groups were described as Low SS group (Low-SSG, SS≤17, n=177), intermediate SS group (In-SSG, SS: 18-28, n=101), and high SS group (High-SSG, SS≥29, n=50). The age, gender, weight, height, body mass index (BMI), and waist circumference of each patient were recorded. EFT was measured by TTE on the next day following CAG.
We excluded the cases with acute or chronic infections, collagen vascular diseases, severe valvular heart disease, arrhythmia, congestive heart failure, previous coronary artery bypass graft (CABG) operations, and percutaneous coronary intervention (PCI). Patients with severe respiratory diseases, liver or kidney diseases with glomerular filtration rate <30 mL/min, and abnormal thyroid function were also excluded from the study. Patients with a slow coronary flow in the absence of any noticeable lesions and morbid obesity were also excluded. All the patients participating in this study were informed about the aim of the study, including oral and written information regarding the procedure, and the study was approved by the local ethics committee (local ethics committee number: 80576354-050-99/60).
Biochemical parameters
Blood sampling was done with standard phlebotomy. Samples were collected in the early morning on the next day following CAG. Biochemical parameters of total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), serum creatinine, and C-reactive protein (CRP) were tested. Complete blood count including white blood cell (WBC) count, lymphocyte count (LC), neutrophil count (NC), and neutrophil-lymphocyte ratio (NLR) were measured.
Clinical variables
Hypertension (HT) was defined as systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, and patient's already using antihypertensive medication. Diabetes mellitus (DM) was defined as fasting glucose >126 mg/dL and patients already using antidiabetic medication. Hypercholesterolemia (HpC) was defined as total cholesterol >200 mg/dL and patients already using a cholesterol-lowering agent. Cigarette smoker was defined as a patient who smoked at least one cigarette per day in the year. A family history of CAD was defined as having a first-degree relative with a documented history of myocardial infarction or sudden death.
Epicardial fat tissue measurements
All the patients were checked for TTE imaging using the Vivid 7 System (GE Vingmed Ultrasound AS; Horten, Norway) with a 2.5-MHz transducer. All the echocardiograms were recorded on a digital storage device and analyzed offline for EFT measurements. All the echocardiographic measurements were performed and reviewed by a single cardiologist who had a substantial specialty in echocardiography to avoid variability between the observers. The observer was blinded to the clinical, biochemical, and angiographic data of the patients.
Epicardial fat tissue appears more frequently as echo-free space rather than hyperechoic space between the linear echo-dense parietal pericardium and right ventricular epicardium in the transthoracic long-and short-axis windows (3). EFT was measured according to Iacobellis et al. (16, 17) from the standard parasternal long-and short-axis views obtained in the left lateral decubitus position. We commonly used the aortic annulus as the anatomical reference to increase the confidence of the results. EFT was measured over the nearest axis next to the anatomic reference point where it was the widest. EFT was also measured perpendicularly to the free wall of the right ventricle at the end-diastole for at least three cardiac cycles ( Figure 1 ). The mean value of these measurements was recorded.
Syntax score
Syntax score, an angiographic grading tool, was used to determine the complexity of CAD. This scoring system was developed from a combination of various grading systems, such as Bypass Angioplasty Revascularization Investigation (BARI) protocol, modified Arterial Revascularization Therapies Study ARTS, modified Leaman score, American College of Cardiology/American Heart Association (ACC/AHA) classification system, Duke and International Classification for Patient Safety, and the total occlusion classification grading system (18) (19) (20) (21) (22) (23) . The SS is based on complex parameters such as diameter reduction and the number of lesions, total occlusions, bifurcation or trifurcation lesions, aorto-ostial stenosis, tortuosity, length, calcification, thrombus, and widespread disease or small vessels (18) . The SS of all the patients were calculated online using SS calculator software (version 2.02, Boston Scientific, Syntax Score Calculator). According to the online SS calculator, stenosis ≥20% in any coronary artery was defined as CAD. Stenosis between 20% and 50% was defined as minimal CAD and stenosis more than 50% was identified as significant CAD. Stenosis less than 20% was defined as normal. Statistical analysis Statistical analyzes were carried out using the Statistical Package for the Social Sciences software for Windows, version 20.0 (IBM Corp.; Armonk, NY, USA). The distribution of the continuous variables was tested by using Skewness/Sd error rate. Skewness/Sd error rate in the range of ±1.96 was accepted as normal distribution. Normally distributed data were expressed as mean±standard deviation (SD) and non-distributed data were expressed as median and interquartile ratio (IQR). Categorical variables were defined as a percentage. Non-distributed values such as the CRP, WBC, LC, and NC were converted to parametric values with log-10 logarithmic transformation. Skew-distributed continuous variables were compared using the one-way ANOVA. Tukey's HDS test was used for pairwise comparison of the groups. Non-skew-distributed continuous variables were compared using the Kolmogorov-Smirnov test. For categorical variables, chi-square test was used. Correlations among the parametric data were tested by Pearson correlation test, and correlations among the non-parametric data were examined by Spearman correlation tests. Multivariate analysis was performed to determine the factors related to epicardial fat thickness. Statistical significance was set at p<0.05.
RESULTS
In this study, 328 patients who underwent CAG with the diagnosis of NSTEMI were included. The mean age of Low-SSG (59.2±10.3 years), In-SSG (63.2±9.2 years), and High-SSG (71.7±6.0 years) were recorded, and there were significant differences in the three groups (p<0.001). Further, there were significant differences among the three groups regarding some baseline clinical and demographic characteristics. These differences included age, height, weight, presence of HT, DM history, hyperlipidemia (HPL) history, fasting plasma glucose (FPG) level, hemoglobin-A1C (HbA1C) level, TC and LDL-C, troponin-I (Tr-I), and left ventricle ejection fraction (LVEF). The demographic and clinical characteristics of the patients are shown in Table 1 .
The mean values of EFT were measured in Low-SSG (5.12±1.13 mm), In-SSG (5.79±0.83 mm), and High-SSG (6.65±0.82 mm) ( Table 2 ). There was a significant difference between mean EFT among the groups (p<0.001). When the groups were compared in pairs, significant differences were also demonstrated between Low-SSG and In-SSG (p<0.001) as well as between Low-SSG and High-SSG (p<0.001) (Figure 2 ).
The median value of CRP in Low-SSG (0.52; 0.35-0.90), In-SSG (0.70; 0.50-1.00), and High-SSG (1.10; 0.84-1.43) were recorded (Table 2 ). There was a significant difference in the mean CRP levels between the three groups (p<0.001). There were significant differences between the groups with regard to the median values of Low-SSG and In-SSG (p<0.001), Low-SSG and High-SSG (p<0.001), and In-SSG and High-SSG (p<0.001). However, no significant correlation was found between In-SSG and High-SSG (p>0.061). Multivariate analysis showed that CRP (odds ratio (OR) 0.435, p<0.001), Tr-I (OR 0.218, p<0.001), and SS (OR 0.454, p<0.001) were independent factors affecting the epicardial fat thickness (Table 4) .
Severity coronary lesion distribution percentages among groups are listed in Table 3 . EFT and percentage of severity coronary lesions were found to increase proportionally as the SS increased. In each group, the LAD was found to have the highest ratio in terms of the severity lesions, followed by Cx and RCA. In addition, Pearson correlation analyzes demonstrated that EFT had a significant influence on the distribution of severity coronary artery lesions of LAD, Cx, and RCA [(r=0.260, p<0.001; r=0.213, p=0.001; and r=0.275, p<0.001, respectively) ( Table 5) ].
DISCUSSION
In our study, we demonstrated that EFT was positively correlated with SS in patients with NSTEMI and was independent of clinical characteristics including age, DM, and HbA1C. Increased EFT may reflect the atherosclerotic burden with an increased number and percentage of severity coronary artery lesions. EFT has been positively correlated with the atherosclerotic burden of LAD, LADD1, LADD2, Cx, and RCA, except LMCA and CxOM1-3. The branches of Cx have weak correlation, while LAD (and its branches), Cx, and RCA have a strong correlation. This may be because LAD, Cx, and RCA have larger epicardial fat around them as compared to their main branches. In addition, SS, age, FBG, HDL-C, TG, and HgA1C were correlated with blood cell count, CRP, and LVEF. This may be a useful predictive tool for coronary artery complexity in NSTEMI.
The epicardial fat tissue is concentrated on the atrioventricular and interventricular grooves and along the major branches of the coronary arteries. It is widely recognized that the accumulation of epicardial fat tissue is strongly related to the development of atherosclerotic CAD (4, 17, 24, (24) (25) (26) (27) (28) . Certain locally secreted bioactive molecules including low-molecular-weight adiponectin, resistin, interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, and monocyte chemotactic protein (MCP)-1 may affect the immunologic and inflammatory responses and, therefore, contribute toward the development of CAD (5, (29) (30) (31) . Some sources have suggested the possible mechanism of increased EFT in the development and progression of CAD by decreasing the synthesis of anti-inflammatory cytokines (adiponectin and resistin) and increasing the synthesis of inflammatory cytokines (IL-1, IL-6, and TNF-α) (5-8, 13, 16) .
Although the relationship between EFT and CAD has been demonstrated in some studies, there are only a limited number of publications demonstrating the correlation between EFT and CAD complexity. Wang T. et al. (32) suggested that EFT could serve as a marker of severe CAD in patients with acute myocardial infarction (AMI). This study highlights the correlation between echocardiographic EFT and the severity of CAD. The results showed that EFT in High-SSG (5.6±1.1 mm) was significantly greater than that in Low-SSG (4.1±1.0 mm) (p<0.01). EFT had a positive correlation with SS and the severity of CAD. These results are in agreement with our findings. Further, that study showed a significant positive correlation with BMI, waist circumference, LDL, and serum TG levels. The authors emphasized that EFT measured by TTE was significantly correlated with severe multiple coronary artery stenosis in patients with AMI. They concluded that EFT could be used for the risk stratification of those patients. Fukamachi et al. (33) investigated the association between EFT and the presence of multivessel CAD in patients with AMI undergoing primary PCI. They found that EFT in patients with multi-vessel CAD (2.8±1.3 mm) was significantly greater than that in the patients with single-vessel disease (1.9±0.9 mm) (p=0.005). EFT was the only independent predictor of multi-vessel CAD. The authors also emphasized that EFT was closely associated with the presence of multi-vessel CAD in patients with AMI. Picard et al. (34) suggested that EFT measured by CT was correlated with the presence and extent of angiographically proven CAD. Another study investigated whether there was a relationship between EFT and the severity and prognosis of acute coronary syndrome (ACS) (35) . In that study, EFT was correlated with the angiographic severity of ACS, but was not correlated with the clinical outcome. It has been reported that the selective surgical excision of adipose tissue in direct contiguity with an epicardial coronary artery attenuated the progression of atherosclerosis in pigs (36) . According to these results, it may be hypothesized that factors generated by the epicardial adipose tissue could contribute toward atherogenesis by direct diffusion through adventitia into the coronary intima-media and might locally contribute to stenosis progression.
We found that SS had a significant positive correlation with EFT. We also found a statistically significant difference between High-SSG, Low-SSG, and In-SSG. This was further intensified by the presence of a significant difference between Low-SSG and In-SSG. Additionally, positive correlation existed between EFT and BMI, HbA1C, and Tr-I measurements. Our results are in accordance with Gul et al. (37) who investigated whether endsystolic and end-diastolic EFT was more closely associated with NSTEMI patients according to the Global Registry of Acute Coronary Events (GRACE) risk score (GS). They found that both endsystolic and end-diastolic EFT values were increased in high GS patients as compared to those of low-moderate GS patients. In addition, the GS showed a positive correlation with end-systolic and end-diastolic EFT.
Epicardial fat thickness is an active organ that secretes several proinflammatory cytokines (3, (5) (6) (7) . In recent years, NLR has been used as a marker of inflammation and has been shown to be an independent predictor of mortality in ischemic heart disease (38). Ozcicek et al. (39) showed that NLR levels were independently associated with EFT in patients with end-stage renal disease receiving hemodialysis. Another study found that NLR and EFT were increased in non-dipper hypertensive patients and they were significantly correlated with each other (40) . In the present study, although patients with more complex CAD had significantly higher levels of NLR, we did not find any correlation between NLR and EFT.
Study limitations
There are some limitations to this study. First, the present study has a small sample size. Second, it is a single-center study. Third, there are other techniques, such as TTE, MRI (the golden standard for EFT assessment), and multidetector CT, for the detection of EFT. While MRI and multidetector CT can be used to readily evaluate EFT, these methods are not always easily accessible and applicable. We used echocardiography to assess the quantitative value of EFT. Echocardiographic EFT measurement is a linear measure at a single location and may not exactly represent the total EFT volume. However, the echocardiographic assessments of EFT are simple, practical, repeatable, readily available, and applicable to perform in a coronary care unit. The fourth limitation is that all the echocardiographic measurements were performed by a single cardiologist, and this may have caused some intraobserver variability of the measurements.
CONCLUSION
Epicardial fat thickness can be quantified in vivo in patients with CAD in an objective manner by TTE. Increased EFT is associated with coronary artery lesion complexity and shown to have positive correlations in patients with NSETMI. This study suggests that EFT measured by TTE may be used as a risk marker in these patient groups. Additionally, as EFT increases around the coronaries, the risk of severity coronary lesion development is also increased. EFT may locally interact and modulate the coronary arteries through the release of proinflammatory adipokines and contribute to the development and progression of CAD. These results indicate that EFT should be checked properly, as well as the other coronary risk factors (HPL, DM, smoking, HT, etc.).
